Search results for "Guidelines as Topic"

showing 10 items of 372 documents

Eminence, or rather eloquence, or rather economy-based medicine?

2004

Marketing of Health Servicesbusiness.industryUrologyObstetrics and GynecologyHealth Care CostsUterine ProlapsePractice Guidelines as TopicQuality of LifeEconomic historyHumansMedicineFemalebusinessFecal IncontinenceSocieties MedicalRandomized Controlled Trials as TopicInternational Urogynecology Journal and Pelvic Floor Dysfunction
researchProduct

Essay: Evidence-based medicine (EBM): New paradigm or integration?

2015

Medical educationPhysician-Patient RelationsEvidence-Based MedicineHepatologyPractice patternsbusiness.industryClinical Decision-MakingGastroenterologyMEDLINEEvidence-based medicine030204 cardiovascular system & hematologyThinking03 medical and health sciences0302 clinical medicineClinical decision makingPractice Guidelines as TopicMedicineHumans030212 general & internal medicinePractice Patterns Physicians'businessQuality of Health CareDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

2009

A current goal of the Italian Society for Thrombosis and Haemostasis (SISET) is the production of guidelines for clinical conditions related to haemostasis and thrombosis. In 2006, the Executive Committee of SISET adopted a new program for the production of methodologically and scientifically sound guidelines aimed at both addressing clinical practice and stimulating new research. The first major step for this program was to train methodologists to manage working groups that compose the guidelines, and to create a reference document that describes the development of the program. The aim of the present paper is to report a short version of this methodological document, for those who wish to …

Medical educationReference DocumentHemostasisbusiness.industryThrombosisHematologyGuidelineSettore MED/15 - Malattie Del SangueClinical Practiceguidelines methodologyGuideline implementationItalyMultidisciplinary approachEVIDENCE BASED MEDICINEPractice Guidelines as TopicMedicineHumansGuideline developmentGrading (education)businessWorking groupThrombosis research
researchProduct

Minimum information about a biofilm experiment (MIABiE): standards for reporting experiments and data on sessile microbial communities living at inte…

2014

The minimum information about a biofilm experiment (MIABiE) initiative has arisen from the need to find an adequate and scientifically sound way to control the quality of the documentation accompanying the public deposition of biofilm-related data, particularly those obtained using high-throughput devices and techniques. Thereby, the MIABiE consortium has initiated the identification and organization of a set of modules containing the minimum information that needs to be reported to guarantee the interpretability and independent verification of experimental results and their integration with knowledge coming from other fields. MIABiE does not intend to propose specific standards on how biof…

Microbiology (medical)Databases FactualStandardizationComputer sciencemedia_common.quotation_subjectControl (management)Microbial communitiesGuidelines as TopicDocumentationBioinformaticsArticleBasic medicine03 medical and health sciencesDocumentationData standardizationTerminology as Topic:Basic medicine [Medical and Health sciences]HumansImmunology and AllergyQuality (business)Data interchangeSet (psychology)030304 developmental biologyInterpretabilitymedia_common0303 health sciencesScience & TechnologyGeneral Immunology and Microbiology030306 microbiologyBiofilmResearchMachine-readable formatsComputational Biology:Medicina básica [Ciências médicas e da saúde]General MedicineData scienceMetadataIdentification (information)Infectious DiseasesVocabulary ControlledResearch DesignMedicina básicaBiofilmsSoftwarePathogens and Disease
researchProduct

Chronic hepatitis B: who to treat and which choice of treatment?

2009

The goal of antiviral therapy in patients with chronic hepatitis B is to prevent, through persistent suppression of HBV replication, cirrhosis and hepatocellular carcinoma. Currently, seven drugs are available: IFN-alpha, pegylated interferon, lamivudine, adefovir dipivoxil, entecavir, telbivudine and tenofovir. The choice of the drugs should always take into consideration the clinical features of patients, the antiviral efficacy of each drug, the risk of developing resistance, the long-term safety profile, the method of administration and the cost of therapy. Ideal candidates for treatment are hepatitis B e antigen-positive patients with a prolonged phase of immune clearance and hepatitis …

Microbiology (medical)Liver Cirrhosismedicine.medical_specialtyHepatitis B virusCarcinoma Hepatocellularmedicine.disease_causeVirus ReplicationMicrobiologyGastroenterologyAntiviral AgentsDrug Administration ScheduleHepatitis B ChronicPegylated interferonVirologyTelbivudineInternal medicineDrug Resistance ViralmedicineAdefovirHumansRandomized Controlled Trials as TopicHepatitis B virusbusiness.industryNucleotidesLamivudineNucleosidesEntecavirHepatitis Bmedicine.diseaseVirologyInfectious DiseasesPractice Guidelines as TopicHepatitia BbusinessViral hepatitisantiviral Therapymedicine.drugExpert review of anti-infective therapy
researchProduct

Landmarks for vertebral artery repositioning in bulbar compression syndrome: anatomic and microsurgical nuances

2004

Abstract OBJECTIVE: The purpose of this study was to better elucidate the anatomic relationship between the vertebral artery (VA) along with its perforating vessels and the brainstem to develop anatomic guidelines that would be helpful when decompressing medulla oblongata compressed by the VA. METHODS: Microanatomy dissection was performed in six formalin-fixed cadaveric heads. The VA, posteroinferior cerebellar artery (PICA), anteroinferior cerebellar artery (AICA), and lower brainstem perforators were examined under magnification using a surgical microscope. The outer diameters of the VA, PICA, and AICA were measured. The distance between the VA, lying within the lateral cerebellomedullar…

Microsurgerymedicine.medical_treatmentVertebral arteryDissection (medical)Cisterna magnaMicrovascular anatomyMedulla oblongatamedicine.arterymedicineHumansVertebral arteryVascular compressionmedulla oblongata; microvascular anatomy; vascular compression; vertebral arterybusiness.industrySyndromeAnatomyMicrosurgerymedicine.diseasemedicine.anatomical_structurePractice Guidelines as TopicMedulla oblongataOccipital nerve stimulationSurgeryBrainstemNeurology (clinical)Cerebellar arterybusinessBrain Stem
researchProduct

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

2014

Item does not contain fulltext Plasma triglyceride concentration is a biomarker for circulating triglyceride-rich lipoproteins and their metabolic remnants. Common mild-to-moderate hypertriglyceridaemia is typically multigenic, and results from the cumulative burden of common and rare variants in more than 30 genes, as quantified by genetic risk scores. Rare autosomal recessive monogenic hypertriglyceridaemia can result from large-effect mutations in six different genes. Hypertriglyceridaemia is exacerbated by non-genetic factors. On the basis of recent genetic data, we redefine the disorder into two states: severe (triglyceride concentration >10 mmol/L), which is more likely to have a mono…

Multifactorial InheritanceSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Genome-wide association studyDisease030204 cardiovascular system & hematologyISCHEMIC-HEART-DISEASEBioinformaticshypertriglyceridaemia0302 clinical medicineEndocrinologyGENERAL-POPULATIONHypertriglyceridemiatreatmentmedicine.diagnostic_testREMNANT CHOLESTEROLCombined Modality Therapy3. Good healthLIPASE DEFICIENCYdiagnosiPLASMA TRIGLYCERIDESDENSITY-LIPOPROTEIN CHOLESTEROLCARDIOVASCULAR-DISEASEPractice Guidelines as TopicBiomarker (medicine)Multifactorial Inheritancemedicine.medical_specialty030209 endocrinology & metabolismHealth PromotionArticle03 medical and health sciencesPharmacotherapyInternal medicineInternal MedicinemedicineAnimalsHumansHOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAGenetic Predisposition to DiseaseAlleleGENOME-WIDE ASSOCIATIONLife Stylehypertriglyceridaemia; diagnosis; treatmentTriglyceridesGenetic testingbusiness.industryHypertriglyceridemianutritional and metabolic diseasesmedicine.diseaseEndocrinologyNONFASTING TRIGLYCERIDESbusinessBiomarkersThe lancet. Diabetesendocrinology
researchProduct

Measurement of microalbuminuria – what the nephrologist should know

2005

Nephrologymedicine.medical_specialtymedicine.medical_treatmentMEDLINEAlbuminsInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansRisk factorChromatography High Pressure LiquidTransplantationProteinuriabusiness.industryPrognosismedicine.diseaseSurgeryNephrologyPractice Guidelines as TopicMicroalbuminuriaHemodialysismedicine.symptombusinessBiomarkersKidney diseaseNephrology Dialysis Transplantation
researchProduct

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide

2021

Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. Aim: The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: An individualized approach is required for the management of VVA. Topical low-dose estrogens are effective and also alleviate urinary incontinence and prevent recurrent urinary tract infections. W…

Non-Hormonal Preparationsmedicine.medical_specialtyChronic conditionmedicine.drug_classmedicine.medical_treatmentUrinary systemVaginal DiseasesUrinary incontinenceVulvovaginal atrophyGeneral Biochemistry Genetics and Molecular BiologyVulvovaginal Atrophy03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineHumansEndocrine system030212 general & internal medicineExpert Testimony030219 obstetrics & reproductive medicinebusiness.industryObstetrics and GynecologyEstrogensPostmenopauseTopical EstrogensAdministration IntravaginalEstrogenPractice Guidelines as TopicQuality of LifeFemaleVulvar DiseasesAtrophymedicine.symptombusinessAdjuvantMaturitas
researchProduct

S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 2

2019

Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…

Occupational Medicinemedicine.medical_specialtyConsensusMEDLINETarget audienceDermatologyOccupational medicineImmunocompromised Host030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansHypersensitivity DelayedPediatriciansChildAdverse effectAllergic contact dermatitisbusiness.industryAllergensPatch Testsmedicine.disease3. Good healthTest (assessment)Family medicineDermatitis Allergic ContactPractice Guidelines as TopicFemaleNursing StaffbusinessContact dermatitisDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct